News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pharpoint Research Wins Project Award From Otologic Pharmaceuticals


8/18/2014 10:45:31 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DURHAM, N.C.--(BUSINESS WIRE)--North Carolina-based CRO, PharPoint Research, today announced their award from Otologic Pharmaceuticals for a full service, Phase I clinical trial assessing the safety, tolerability, and pharmacokinetic profile of agents in the treatment of hearing loss.

“Hearing loss is the third most common physical ailment behind arthritis and heart disease,” noted Audra McRae, PharPoint’s Chief Operating Officer. “Using our team’s experience we are excited to work on a product that potentially eases the troubles for those affected by hearing loss.”

Hey, check out all the research scientist jobs. Post your resume today!

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES